Insys Therapeutics News

Former Insys CEO Pleads Guilty to Opioid Bribes; Agrees to Work with Prosecutors

The former chief executive of Insys Therapeutics Inc. pleaded guilty on Wednesday to participating in a nationwide scheme to bribe doctors to prescribe an addictive opioid medication and has agreed to become a government witness. Michael Babich, who resigned as …

Former Insys CEO Babich Pleads Guilty to Opioid Prescription Bribe Scheme

The former chief executive of Insys Therapeutics Inc. has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication in order to boost its sales, U.S. prosecutors said on Wednesday. Michael Babich, …

Troubled Opioid Seller Insys Looks to Cannabis to Save Itself

Sitting in a Boston courtroom in a dark, pinstriped suit, the former top sales executive at Insys Therapeutics Inc., Alex Burlakoff, listened as federal prosecutors read out crimes he and the company had allegedly committed. Insys had bribed doctors and …

Senate Report Links Drugmakers’ Donations to Opioid Crisis

Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said …

Doctor Charged in Rhode Island with Pushing Painkiller, Receiving Kickbacks

A doctor has been indicted on charges accusing him of getting kickbacks on prescriptions of a highly addictive painkiller written for patients who didn’t need the drug. Jerrold Rosenberg, a pain specialist and clinical assistant professor at Brown University, pleaded …